Nextech Named 2024 Best in KLAS: Ambulatory Specialty EHR
February 07, 2024 08:01 ET
|
Nextech Systems, Inc.
Nextech's EHR software is the top-ranked solution in the Ambulatory Specialty EHR category of the 2024 Best in KLAS: Software & Services report.
Medical Laser Market revenue to hit USD 9.5 Billion by 2033, says Research Nester
February 07, 2024 07:00 ET
|
Research Nester
New York , Feb. 07, 2024 (GLOBE NEWSWIRE) -- The global medical laser market size is predicted to grow at a CAGR of over 10% from 2023 to 2033. The market is projected to garner a revenue of USD 9.5...
Drug Delivery Devices Market Surges Towards USD 713.1 Billion by 2033 | Rising prevalence of Advanced Therapies and Chronic Diseases Drives Growth
February 07, 2024 04:47 ET
|
Market.Us
New York, Feb. 07, 2024 (GLOBE NEWSWIRE) -- According to Market.us, the global Drug Delivery Devices Market size is forecasted to exceed USD 713.1 Billion by 2033, with a promising CAGR of 7.9% from...
Global Ophthalmology Market Poised for Robust Growth: Comprehensive Research Forecast 2023-2030 Highlights Disease, Product, and End-User Segments
February 07, 2024 04:30 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Ophthalmology Market by Diseases (Age-Related Macular Degeneration, Cataract, Glaucoma), Product Type (Drugs, Equipment, Prescription Glasses...
Collagen Market Forecast to Reach Remarkable Growth by 2030, Propelled by Advancements in Healthcare and Cosmetics
February 07, 2024 04:27 ET
|
Research and Markets
Dublin, Feb. 07, 2024 (GLOBE NEWSWIRE) -- The "Global Collagen Market by Product Type, Applications (Nutritional Products, Food & Beverages Products, Pharmaceuticals Products, Cosmetics &...
4D Molecular Therapeutics Announces Pricing of Upsized Public Offering of Common Stock
February 06, 2024 23:27 ET
|
4D Molecular Therapeutics, Inc.
EMERYVILLE, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics, Inc. (Nasdaq: FDMT), a leading clinical-stage genetic medicines company focused on unlocking the full potential of...
New Publication in Nature Medicine Supports Therapeutic Potential of Senolytics to Provide Long-lasting, Disease-modifying Intervention in Vision Loss
February 06, 2024 08:00 ET
|
Unity Biotechnology, Inc.
SOUTH SAN FRANCISCO, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- UNITY Biotechnology, Inc. (“UNITY”) [NASDAQ: UBX], a biotechnology company developing therapeutics to slow, halt or reverse diseases of...
Iridex Corporation Receives European Patent on MicroPulse Technology
February 06, 2024 08:00 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., Feb. 06, 2024 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and...
Nicox announces presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024
February 06, 2024 01:30 ET
|
NICOX
Press Release Nicox announces presentations at the upcoming Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting 2024February 6, 2024 – release at 7:30 am CET Sophia Antipolis,...
Nicox : Présentations au prochain Congrès Annuel 2024 de l’Association for Research in Vision and Ophthalmology (ARVO)
February 06, 2024 01:30 ET
|
NICOX
Communiqué de presseNicox : Présentations au prochain Congrès Annuel 2024 de l’Association for Research in Vision and Ophthalmology (ARVO)6 février 2024 – diffusion à 7h30Sophia Antipolis, FranceNicox...